House Committees Request FDA Registrations for Alzheimer’s Drug Approval

Two strong congressional committees investigating the controversial federal approval of Biogen’s Alzheimer’s drug Aduhelm requested extensive information and documentation from the Food and Drug Administration in a letter released Thursday, making it clear that committee leaders were annoyed by the unusual actions the agency took. during the evaluation and approval of the drug. “We are […]

(0)